Neuropace Inc (NPCE) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Neuropace Inc   (NASDAQ: NPCE)


Neuropace Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Neuropace Inc 's ROA in the second quarter of 2026?
Neuropace Inc recorded a cumulative net loss of $-19 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -18.88%.

However, within the Healthcare sector 352 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3466, from total ROA ranking in the first quarter of 2026 at 4056.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change -8.6 % -10.26 % 7.54 % 11.37 % 12.42 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -19 -22 -21 -24 -26
Return On Assets (TTM) -18.88 % -20.83 % -20.19 % -22.94 % -25.48 %
NPCE's Total Ranking # 3466 # 4056 # 3607 # 3691 # 3742
Total Assets (TTM) in million 97 99 102 107 106
Seq. Total Assets Change -1.93 % -2.84 % -5.1 % 1.08 % -3.71 %
Seq. Net Income Change - - - - -

NPCE's 5 Years Annual ROA >> Back to NPCE Management Effectiveness >> Compare NPCE ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 113
Sector # 353
Overall # 3398

Return On Assets Statistics
High Average Low
-18.71 %
-29.69 %
-40.05 %
(Jun 30 2026)   (Mar 31 2023)



  News about Neuropace Inc Return on Assets ROA

NeuroPace’s New Leadership Amidst Financial Struggles: A Strategic Move or a Hail Mary

In a significant shift in its corporate strategy, NeuroPace Inc. a leader in the development of innovative neurostimulation treatments, has recently appointed an experienced people leader as its Vice President of Human Resources. This move comes at a crucial time for the company, which has seen its shares plummet by 21.8% over the past three months, reflecting growing anxieties among investors about its financial health and market viability.The appointment of the new human resources leader signals a potential pivot for NeuroPace, which has been grappling with a staggering cumulative net loss of $33 million over the past 12 months, culminating in a negative return on assets (ROA) of -33.27% as of the second quarter of 2024. These numbers have prompted industry analysts to speculate whether the company can turn its fortunes around or if it will continue to face headwinds that have plagued it recently.



Financial Statements
Neuropace Inc 's Assets $ 97 million NPCE's Balance sheet
Neuropace Inc 's Income $ -6 million Quarterly NPCE's Income Statement
NPCE's Income by Division See NPCE's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 11.54 % -7.19 % -10.63 % -14.57 % -
Total Assets in million 106 95 102 114 134
Y / Y Net Income Change - - - - -
Net Income in million -21 -27 -33 -47 -36
Annual Return On Assets -20.33 % -28.68 % -32.32 % -41.26 % -27.01 %

NPCE's 5 Years Annual ROA >> Back to NPCE Management Effectiveness >> Compare NPCE ROA to its Competitors



More Return On Assets Ratios
NPCE's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
NPCE's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for NPCE's Competitors
Subscribers only: Roa for Neuropace Inc 's Suppliers
Subscribers only: Return On Assets for NPCE's Customers

You may also want to know
NPCE's Roi NPCE's Inventory Turnover Ratio NPCE's Growth Rates NPCE's Dividend Comparisons
NPCE's Profitability Ratios NPCE's Asset Turnover Ratio NPCE's Dividend Growth
NPCE's Roe NPCE's Valuation Ratios NPCE's Financial Strength Ratios NPCE's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-09-04T10:33:25+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.